Cytozyme Eastern India Profile
Key Indicators
- Authorised Capital ₹ 3.50 Cr
as on 16-12-2024
- Paid Up Capital ₹ 2.87 Cr
as on 16-12-2024
- Company Age 44 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 400.29%
(FY 2019)
- Profit 90.82%
(FY 2019)
- Ebitda 1124.20%
(FY 2019)
- Net Worth -0.08%
(FY 2019)
- Total Assets 25.06%
(FY 2019)
About Cytozyme Eastern India
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 2.87 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ravi Pandey and Sheo Pandey serve as directors at the Company.
- CIN/LLPIN
U01409WB1980PTC032844
- Company No.
032844
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jul 1980
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cytozyme Eastern India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravi Pandey  | Director | 15-Dec-2010 | Current |
| Sheo Pandey | Director | 03-Dec-2013 | Current |
Financial Performance and Corporate Structure Insights of Cytozyme Eastern India.
Cytozyme Eastern India Pvt Ltd, for the financial year ended 2019, experienced significant growth in revenue, with a 400.29% increase. The company also saw a substantial improvement in profitability, with a 90.82% increase in profit. The company's net worth dipped by a decrease of 0.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cytozyme Eastern India?
In 2019, Cytozyme Eastern India had a promoter holding of 30.01% and a public holding of 70.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cytozyme Eastern India?
Unlock and access historical data on people associated with Cytozyme Eastern India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cytozyme Eastern India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cytozyme Eastern India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
